GBS Inc. (GBS)’in fiyatı nedir?

GBS Inc. (GBS)’in fiyatı $0.4732’dir

GBS Inc. (GBS)’in piyasa değeri nedir?

GBS Inc. (GBS)’in piyasa değeri $7.05M’dir.

GBS Inc. (GBS) Tedavüldeki Hisseler

Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
Abbott Laboratories ABT.US	1.74B	-	US
Stryker Corporation SYK.US	383.50M	-	US
Medtronic plc MDT.US	1.28B	-	IE
Boston Scientific Corporation BSX.US	1.48B	-	US
Edwards Lifesciences Corporation EW.US	576.40M	-	US

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke